Turner's syndrome

New England Journal of Medicine

Volumn 351, Issue 12, 2004, Pages

  Sybert, Virginia P ^a,c   McCauley, Elizabeth ^b,d  

^a Division of Medical Genetics   (United States)

^b Dept of Psychiat and Behav Sci ^*  (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN; RECOMBINANT GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADULT; BONE DYSPLASIA; CANCER RISK; CATARACT; CHILD; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG SAFETY; EDEMA; ENDOCRINE DISEASE; ENDOMETRIUM CARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; GONADAL DYSGENESIS; GROWTH DISORDER; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INFANT; INSULIN RESISTANCE; KELOID; KIDNEY MALFORMATION; LEARNING DISORDER; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; META ANALYSIS; OBESITY; OSTEOPOROSIS; OTITIS MEDIA; PERCEPTION DEAFNESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SHORT STATURE; STRABISMUS; SYSTEMATIC REVIEW; TURNER SYNDROME; CHROMOSOME ABERRATION; GENETICS; X CHROMOSOME;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, X; FEMALE; GROWTH DISORDERS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; LEARNING DISORDERS; TURNER SYNDROME;

EID: 4544347706     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra030360     Document Type: Review

References (103)

1. Turner HH. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938;23:566-74.
2. Ford CE, Jones KW, Polani PE, de Almeida JC, Briggs JH. A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome). Lancet 1959;1:711-3.
3. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner's syndrome in adulthood. Endocr Rev 2002;23:120-40.
4. Sybert VP. Turner syndrome. In: Cassidy SB, Allanson JE, eds. Management of genetic syndromes. New York: Wiley-Liss, 2001: 459-84.
5. Koeberl DD, McGillivray B, Sybert VP. Prenatal diagnosis of 45,X/46,XX mosaicism and 45,X: implications for postnatal outcome. Am J Hum Genet 1995;57:661-6.
6. Chang HJ, Clark RD, Bachman H. The phenotype of 45,X/46,XY mosaicism: an analysis of 92 prenatally diagnosed cases. Am J Hum Genet 1990;46:156-67.
7. Gravholt CH, Fedder J, Naeraa RW, Müller J, Fisker S, Christiansen JS. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 2000;85:3199-202.
8. Alvarez-Nava F, Soto M, Sanchez MA, Fernandez E, Lanes R. Molecular analysis in Turner syndrome. J Pediatr 2003;142:336-40.
9. Nishi MY, Domenice S, Medeiros MA, Mendonca BB, Billerbeck AEC. Detection of Y-specific sequences in 122 patients with Turner syndrome: nested PCR is not a reliable method. Am J Med Genet 2002;107:299-305. [Erratum, Am J Med Genet 2002;113: 116-7.]
10. Nishi MY, Domenice S, Medeiros MA, Mendonca BB, Billerbeck AEC. Detection of Y-specific sequences in 122 patients with Turner syndrome: nested PCR is not a reliable method. Am J Med Genet 2002;107:299-305. [Erratum, Am J Med Genet 2002;113: 116-7.]
11. Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 1995;95:607-29.
12. Ogata T, Muroya M, Matsuo N, et al. Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 2001;86:5498-508.
13. Zinn AR, Ross JL. Molecular analysis of genes on Xp controlling Turner syndrome and premature ovarian failure (POF). Semin Reprod Med 2001;19:141-6.
14. Idem. Turner syndrome and haploinsufficiency. Curr Opin Genet Dev 1998;8:322-7.
15. Haverkamp F, Wolfle J, Zerres K, et al. Growth retardation in Turner syndrome: aneuploidy, rather than specific gene loss, may explain growth failure. J Clin Endocrinol Metab 1999;84:4578-82.
16. Prueitt RL, Ross JL, Zinn AR. Physical mapping of nine Xq translocation breakpoints and identification of XPNPEP2 as a premature ovarian failure candidate gene. Cytogenet Cell Genet 2000;89:44-50.
17. Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997;16:54-63.
18. Ross JL, Roeltgen D, Kushner H, Wei F, Zinn AR. The Turner syndrome-associated neurocognitive phenotype maps to distal Xp. Am J Hum Genet 2000;67:672-81.
19. Boucher CA, Sargent CA, Ogata T, Affara NA. Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location. J Med Genet 2001;38:591-8.
20. Sybert VP. Phenotypic effects of a mosaicism for a 47,XXX cell line in Turner syndrome. J Med Genet 2002;39:217-21.
21. Elsheikh M, Wass JA, Conway GS. Autoimmune thyroid syndrome in women with Turner's syndrome - the association with karyotype. Clin Endocrinol (Oxf) 2001;55: 223-6.
22. Davenport ML, Punyasavatsut N, Stewart PW, Gunther DF, Savendahl L, Sybert VP. Growth failure in early life: an important manifestation of Turner syndrome. Horm Res 2002;57:157-64.
23. Rosenfeld RG, Attie KM, Frane J, et al. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 1998;132:319-24.
24. Haeusler G, Schmitt K, Blümel P, Plöchl E, Waldhor T, Frisch H. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height. Acta Paediatr 1996;85:1408-14.
25. Takano K, Ogawa M, Tanaka T, Tachibana K, Fujita K, Hizuka N. Clinical trials of GH treatment in patients with Turner's syndrome in Japan - a consideration of final height. Eur J Endocrinol 1997;137:138-45.
26. Sas TCJ, de Muinck Keizer-Schrama SMPF, Stijnen T, et al. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Arch Dis Child 1999;80:36-41.
27. Plotnick L, Attie KM, Blethen SL, Sy JP. Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience. Pediatrics 1998; 102:479-81.
28. Nilsson KO, Albertsson-Wikland K, Alm J, et al. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab 1996;81:635-40.
29. Ranke MB, Partsch CJ, Lindberg A, et al. Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. Eur J Endocrinol 2002;147:625-33.
30. Rochiccioli P, Battin J, Bertrand AM, et al. Final height in Turner syndrome patients treated with growth hormone. Horm Res 1995;44:172-6.
31. Hochberg Z, Zadik Z. Final height in young women with Turner syndrome after GH therapy: an open controlled study. Eur J Endocrinol 1999;141:218-24.
32. Betts PR, Butler GE, Donaldson MDC, et al. A decade of growth hormone treatment in girls with Turner syndrome in the UK. Arch Dis Child 1999;80:221-5.
33. Van den Broeck J, Massa GG, Attanasio A, et al. Final height after long-term growth hormone treatment in Turner syndrome. J Pediatr 1995;127:729-35.
34. Massa G, Otten BJ, de Muinck Keizer-Schrama SM, et al. Treatment with two growth hormone regimens in girls with Turner syndrome: final height results. Horm Res 1995; 43:144-6.
35. Chu CE, Paterson WF, Kelnar CJH, Smail PJ, Greene SA, Donaldson MDC. Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner's syndrome. Acta Paediatr 1997;86: 160-4.
36. Taback SP, Collu R, Deal CL, et al. Does growth-hormone supplementation affect adult height in Turner's syndrome? Lancet 1996;348:25-7.
37. van Pareren YK, de Muinck Keizer-Schrama SMPF, Stijnen T, et al. Final height in Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogen. J Clin Endocrinol 2003; 88:1119-25.
38. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child 1985;60:932-5.
39. Haeusler G, Frisch H. Methods for evaluation of growth in Turner's syndrome: critical approach and review of the literature. Acta Paediatr 1994;83:309-14.
40. Canadian Growth Hormone Advisory Committee. Growth hormone treatment to final height in Turner syndrome: a randomized controlled trial. Horm Res 1998;50: Suppl 3:25. abstract
41. Donaldson MD. Growth hormone therapy in Turner syndrome - current uncertainties and future strategies. Horm Res 1997;48:Suppl 5:35-44.
42. Bramswig JH. Expectation bias with respect to growth hormone therapy in Turner syndrome. Eur J Endocrinol 1997;137:446-7.
43. Cave CB, Bryant J, Milne R. Recombinant growth hormone in children and adolescents with Turner syndrome. Cochrane Database Syst Rev 2003;3:CD003887.
44. Van Pareren YK, De Muinck Keizer-Schrama SMPF, Stijnen T, Sas TC, Drop SL. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. J Clin Endocrinol 2003;87:5442-8.
45. Silverman BL, Friedlander JR. Is growth hormone good for the heart? J Pediatr 1997; 131:S70-S74.
46. Pavlidis K, McCauley E, Sybert VP. Psychosocial and sexual functioning in women with Turner syndrome. Clin Genet 1995;47: 85-9.
47. Delgado JA, Trahms CM, Sybert VP. Measurement of body fat in Turner syndrome. Clin Genet 1986;29:291-7.
48. Ross JL, Zinn A, McCauley E. Neurodevelopmental and psychosocial aspects of Turner syndrome. Ment Retard Dev Disabil Res Rev 2000;6:135-41.
49. Ross JL, Stefanatos G, Roeltgen D, Kushner H, Cutler GB Jr. Ullrich-Turner syndrome: neurodevelopmental changes from childhood through adolescence. Am J Med Genet 1995;58:74-82.
50. Rovet J. The cognitive and neuropsychological characteristics of females with Turner syndrome. In: Berch DB, Bender BG, eds. Sex chromosome abnormalities and behavior: psychological studies. Boulder, Colo.: AAAS/Westview Press, 1990:38-77.
51. O'Connor J, Fitzgerald M, Hoey H. The relationship between karyotype and cognitive functioning in Turner syndrome. Ir J Psychol Med 2000;17:82-5.
52. Skuse DH, James RS, Bishop DV, et al. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 1997;387:705-8.
53. Habrecht MF, Menon V, Warsofsky IS, et al. Functional neuroanatomy of visuo-spatial working memory in Turner syndrome. Hum Brain Mapp 2001;14:96-107.
54. Elliot TK, Watkins JM, Messa C, et al. Positron emission tomography and neuropsychological correlations in children with Turner's syndrome. Dev Neuropsychol 1996; 12:365-86.
55. Buchanan L, Pavlovic J, Rovet J. A reexamination of the visuospatial deficit in Turner syndrome: contributions of working memory. Dev Neurospsychol 1998;14:341-67.
56. Romans S, Roeltgen DP, Kushner H, Ross JL. Executive function in girls with Turner's syndrome. Dev Neuropsychol 1997; 13:23-40.
57. Temple C, Carney RA, Mullarkey S. Frontal lobe function and executive skills in children with Turner's syndrome. Dev Neuropsychol 1996;12:343-63.
58. Rourke BP. Syndrome of nonverbal learning disabilities: neurodevelopmental manifestations. New York: Guilford Press, 1995.
59. Mazzocco M. Math learning disability and math LD subtypes: evidence from studies of Turner syndrome, fragile X syndrome, and neurofibromatosis type 1. J Learn Disabil 2000;34:520-33.
60. Temple C, Marriott AJ. Arithmetical ability and disability in Turner's syndrome: a cognitive neuropsychological analysis. Dev Neurospsychol 1998;14:47-67.
61. McCauley E, Feuillan P, Kushner H, Ross JL. Psychosocial development in adolescents with Turner syndrome. J Dev Behav Pediatr 2001;22:360-5.
62. Downey J, Ehrhardt AA, Gruen R, Bell JJ, Morishima A. Psychopathology and social functioning in women with Turner syndrome. J Nerv Ment Dis 1989;177:191-201.
63. McCauley E. Psychosocial aspects of the Turner syndrome. In: Berch DB, Bender BG, eds. Sex chromosome abnormalities and behavior: psychological studies. Boulder, Colo.: AAAS/Westview Press, 1990:78-99.
64. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51: 8-19.
65. Rovet J, Ireland L. Behavioral phenotype in children with Turner syndrome. J Pediatr Psychol 1994;19:779-90.
66. McCauley E, Kay T, Ito J, Treder R. The Turner syndrome: cognitive deficits, affective discrimination, and behavior problems. Child Dev 1987;58:464-73.
67. McCauley E, Ross JL, Kushner H, Cutler G Jr. Self-esteem and behavior in girls with Turner syndrome. J Dev Behav Pediatr 1995; 16:82-8. [Erratum, J Dev Behav Pediatr 1995; 16:210.]
68. McCauley E, Ross JL, Kushner H, Cutler G Jr. Self-esteem and behavior in girls with Turner syndrome. J Dev Behav Pediatr 1995; 16:82-8. [Erratum, J Dev Behav Pediatr 1995; 16:210.]
69. Ross JL, McCauley E, Roeltgen D, et al. Self-concept and behavior in adolescent girls with Turner syndrome: potential estrogen effects. J Clin Endocrinol Metab 1996;81: 926-31. [Erratum, J Clin Endocrinol Metab 1996;81:2191.]
70. Ross JL, McCauley E, Roeltgen D, et al. Self-concept and behavior in adolescent girls with Turner syndrome: potential estrogen effects. J Clin Endocrinol Metab 1996;81: 926-31. [Erratum, J Clin Endocrinol Metab 1996;81:2191.]
71. Lawrence K, Kuntsi J, Coleman M, Campbell R, Skuse D. Face and emotion recognition deficits in Turner syndrome: a possible role for X-linked genes in amygdala development. Neuropsychology 2003;17: 39-49.
72. Sylvén L, Magnusson C, Hagenfeldt K, von Schoultz B. Life with Turner's syndrome - a psychosocial report from 22 middle-aged women. Acta Endocrinol (Copenh) 1993;129:188-94.
73. Ross J, Stefanatos GA, Kushner H, Zinn A, Bondy C, Roeltgen D. Persistent cognitive deficits in adult women with Turner syndrome. Neurology 2002;58:218-25.
74. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1995;101(1):e11 (Web only). (Available at http://www.pediatrics.org/cgi/ content/full/101/1/e11.)
75. Gotzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 1994;71:433-6.
76. Price WH, Clayton JF, Collyer S, De Mey R, Wilson J. Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. J Epidemiol Community Health 1986;40:97-102.
77. Elsheikh M, Casadei B, Conway GS, Wass JAH. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol (Oxf) 2001;54:69-73.
78. Lin AE, Lippe BM, Geffner ME, et al. Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr 1986;109:820-6.
79. Lin AE, Lippe B, Rosenfeld RG. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics 1998;102(1):e12 (Web only). (Available at http://www.pediatrics. org/cgi/content/full/102/1/e12.)
80. Germain EL, Plotnick LP. Age-related anti-thyroid antibodies and thyroid abnormalities in Turner syndrome. Acta Paediatr Scand 1986;75:750-5.
81. Modi DN, Sane S, Bhartiya D. Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol Hum Reprod 2003;9:219-25.
82. Sybert VP. Adult height in Turner syndrome with and without androgen therapy. J Pediatr 1984;104:365-9.
83. Guttmann H, Weiner I, Nikolski E, et al. Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin Endocrinol (Oxf) 2001;54:159-64.
84. Albareda MM, Gallego A, Enriquez J, Rodriguez JL, Webb SM. Biochemical liver abnormalities in Turner's syndrome. Eur J Gastroenterol Hepatol 1999;11:1037-9.
85. Elsheikh N, Hodgson HJ, Wass JA, Conway GS. Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clin Endocrinol (Oxf) 2001;55:227-31.
86. Hasle H, Olsen JH, Nielsen J, Hansen J, Friedrich U, Tommerup N. Occurrence of cancer in women with Turner syndrome. Br J Cancer 1996;73:1156-9.
87. Tarani L, Lampariello S, Raguso G, et al. Pregnancy in patients with Turner's syndrome: six new cases and review of literature. Gynecol Endocrinol 1998;12:83-7.
88. Karnis MF, Zimon AE, Lalwani SI, Timmreck LS, Klipstein S, Reindollar RH. Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey. Fertil Steril 2003; 80:498-501.
89. Chrousos GA, Ross JL, Chrousos G, et al. Ocular findings in Turner syndrome: a prospective study. Ophthalmology 1984;91:926-8.
90. Hultcrantz M, Sylvén L, Borg E. Ear and hearing problems in 44 middle-aged women with Turner's syndrome. Hear Res 1994; 76:127-32.
91. Mathisen B, Reilly S, Skuse D. Oral-motor dysfunction and feeding disorders of infants with Turner syndrome. Dev Med Child Neurol 1992;34:141-9.
92. Arulanantham K, Kramer MS, Gryboski JD. The association of inflammatory bowel disease and X chromosomal abnormality. Pediatrics 1980;66:63-7.
93. Ivarsson SA, Carlsson A, Bredberg A, et al. Prevalence of coeliac disease in Turner syndrome. Acta Paediatr 1999;88:933-6.
94. Bonamico M, Pasquino AM, Mariani P, et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab 2002;87:5495-8.
95. Lippe B, Geffner ME, Dietrich RB, Boechat MI, Kangarloo H. Renal malformations in patients with Turner syndrome: imaging in 141 patients. Pediatrics 1988;82: 852-6.
96. Bakalov VK, Chen ML, Baron J, et al. Bone mineral density and fractures in Turner syndrome. Am J Med 2003;115: 259-64.
97. Ross JL, Long LM, Feuillan P, Cassorla F, Cutler GB Jr. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. J Clin Endocrinol Metab 1991;73:355-9.
98. Landin-Wilhelmsen K, Bryman I, Windh M, Wilhelmsen L. Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf) 1999;51:497-502.
99. Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen JS. Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf) 2003;59:89-96.
100. Hogler W, Briody J, Moore B, Garnett S, Lu PW, Cowell CT. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy x-ray absorptiometry. J Clin Endocrinol Metab 2004;89:193-9.
101. Larralde M, Gardner SS, Torrado M, et al. Lymphedema as a postulated cause of cutis verticis gyrata in Turner syndrome. Pediatr Dermatol 1998;15:18-22.
102. Swerdlow AJ, Hermon C, Jacobs PA, et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet 2001; 65:177-88.
103. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-58.